The Smart Vital System Utilizes Cameras and AI to Screen Vital Signs for Potential COVID-19 Symptoms
Los Angeles, CA, Dec. 15, 2020 (GLOBE NEWSWIRE) — Draganfly Inc. (OTCQB: DFLYF) (CSE: DFLY) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading manufacturer and systems developer, is pleased to announce that the Alabama State Senate is taking delivery of the Draganfly Vital Intelligence Smart Vital system to detect potential symptoms of COVID-19.
The Smart Vital system monitors, with voluntary consent, vital signs including but not limited to temperature, heart rate, breathing rate and blood oxygen content (SpO2). The system does not register any personal data of the individual being screened.
The Alabama Department of Public Health reported a record high 3,531 new cases as of December 4, 2020 and the state has averaged 2,461 cases each day for the last two weeks, a 28 percent increase over the previous two weeks.
The Alabama State Senate is taking delivery of Draganfly’s Smart Vital screening system and will work with Draganfly’s platform to provide comprehensive data to help ensure the safety of all stakeholders who rely on the ongoing operation of government. The Smart Vital system is North American made and owned.
Data provided to the Alabama State Senate will include the number of people screened, number of elevated vital signs detected and the time it took for each screening. If a screening detects elevated vital signs, the individual will be notified immediately that they need to be tested for COVID-19. The platform does not record vital results for each individual.
“As the current pandemic continues, we are committed to provide a safe place for our staff and visitors to ensure there is no interruption in the work that needs to be done for the citizens of Alabama,” said Pat Harris, Secretary, Alabama State Senate. “We are confident that the implementation of Draganfly’s Vital Intelligence Technology will help to ensure an important layer to existing protocols that assist us in identifying and mitigating the risk of the spread of COVID-19.”
“It is a great honour that the Alabama Senate has chosen Draganfly to implement our Vital Intelligence technology,” said Cameron Chell, CEO of Draganfly. “We are humbled by their trust in our technology and we are looking forward to this long-term partnership to help the Alabama Senate’s COVID-19 protocols.”
Alabama State University recently installed Draganfly’s Vital Intelligence Smart Thermal + Vital screening and Social Distancing Awareness system across its campus. Measuring real-time anonymous data which has previously not been available, students, faculty and staff can receive, within seconds, contactless temperature, heart rate and respiratory rate readings. Since installation, the University has also seen significant increases in adherence to social distancing protocols.
Draganfly Inc. (CSE: DFLY; OTCQB: DFLYF; FSE: 3U8) is the creator of quality, cutting-edge software and systems that revolutionize the way organizations can do business and service their stakeholders. Recognized as being at the forefront of technology for over 22 years, Draganfly is an award-winning, industry-leading manufacturer and technology developer serving the public safety, agriculture, industrial inspections, security, and mapping and surveying markets. Draganfly is a company driven by passion, ingenuity, and the need to provide efficient solutions and first-class services to its customers around the world with the goal of saving time, money, and lives.
For more information on Draganfly, please visit us at www.draganfly.com.
For additional investor information, visit https://www.thecse.com/en/listings/technology/draganfly-inc, https://www.otcmarkets.com/stock/DFLYF/overview or https://www.boerse-frankfurt.de/aktie/draganfly-inc.
email: [email protected]
Email: [email protected]
This release contains certain “forward looking statements” and certain “forward-looking information” as defined under applicable Canadian securities laws. Forward-looking statements and information can generally be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “continue”, “plans” or similar terminology. Forward-looking statements and information are based on forecasts of future results, estimates of amounts not yet determinable and assumptions that, while believed by management to be reasonable, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Forward-looking statements include, but are not limited to, statements with respect to the viability and continued use of the Company’s Vital Intelligence Technology and the successful utilization and integration of the technology. Forward-looking statements and information are subject to various known and unknown risks and uncertainties, many of which are beyond the ability of the Company to control or predict, that may cause the Company’s actual results, performance or achievements to be materially different from those expressed or implied thereby, and are developed based on assumptions about such risks, uncertainties and other factors set out here in, including but not limited to: the potential impact of epidemics, pandemics or other public health crises, including the current outbreak of the novel coronavirus known as COVID-19 on the Company’s business, operations and financial condition, the successful integration of technology, the inherent risks involved in the general securities markets; uncertainties relating to the availability and costs of financing needed in the future; the inherent uncertainty of cost estimates and the potential for unexpected costs and expenses, currency fluctuations; regulatory restrictions, liability, competition, loss of key employees and other related risks and uncertainties disclosed under the heading “Risk Factors“ in the Company’s most recent filings filed with securities regulators in Canada on the SEDAR website at www.sedar.com. The Company undertakes no obligation to update forward-looking information except as required by applicable law. Such forward-looking information represents managements’ best judgment based on information currently available. No forward-looking statement can be guaranteed and actual future results may vary materially. Accordingly, readers are advised not to place undue reliance on forward-looking statements or information.